Summary:
- The U.S. Food and Drug Administration (FDA) has approved a new drug called Lynkuet to treat hot flashes associated with menopause.
- Lynkuet is a non-hormonal medication that works by targeting the neurotransmitter norepinephrine, which is involved in regulating body temperature.
- This new treatment option provides an alternative for women who are unable or unwilling to use hormone therapy to manage their menopausal symptoms.